This international conference brings together World leading researchers of different disciplines: physicists and medical physicists, chemists, biologists, medical doctors and SMEs with the aim of presenting their results of exploiting and understanding the nanoscale processes, towards the development and optimization of new nanodrugs together with novel radiation protocols. It will be held on 22-24 January 2018 at CNRS (Gif-sur-Yvette, Paris region), France.
Cancer remains a major European health concern. More than 50% of patients receive radiotherapy as part of their cancer treatment. The main limitations of this treatment are the lack of tumour selectivity, which causes severe side effects, and the radioresistance of tumours. Highly promising approaches to improve the performances of radiation-based therapies include advanced radiation protocols (such as fast ion beam radiation or ultra-high-dose rate radiation) and nanoparticle-enhanced therapies.
- Biological effect of nanoparticles combined with photon or particle therapy
- Elementary mechanisms and nanodosimetry
- Nanomaterials for radiation-based cancer therapies
- Simulations of radiation effects
- Medical and industrial perspectives
Keywords: radiotherapy, cancer treatment, cancer, nanoparticles, nanomedicine, irradiation, nanodrugs
More information on https://argent.sciencesconf.org/